Screener
SELLAS Life Sciences Group, Inc. SLS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Loss from operations | (9,252) | (6,063) |
| Non-operating income: | ||
| Interest income | 845 | 250 |
| Total non-operating income | 845 | 250 |
| Net loss | $(8,407) | $(5,813) |
| Per share information: | ||
| Net loss per common share, basic and diluted | $(0.05) | $(0.07) |
| Weighted-average common shares outstanding, basic and diluted | 172,481,541 | 87,760,320 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is SELLAS Life Sciences Group, Inc.'s net income?
- SELLAS Life Sciences Group, Inc. (SLS) reported net income of -$8.41M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s net income changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s net income decreased by 44.6% year-over-year, from -$5.81M to -$8.41M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s net income?
- Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s net income has grown at a 6.7% compound annual growth rate (CAGR), from -$20.7M to -$26.86M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about SELLAS Life Sciences Group, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude